ABSTRACT A patient with the acquired immunodeficiency syndrome (AIDS) developed severe cyanosis after bronchoscopy (oxygen saturation 34%) from methaemoglobinaemia. This was thought to be due to enhanced absorption of local anaesthetic from the nasopharynx or trachea as a result of candidiasis. The patient responded dramatically to intravenous methylene blue.
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Severe cyanosis during or after bronchoscopy usually results from hypoxaemia from pneumothorax, pulmonary haemorrhage, or bronchoconstriction. We report a patient with the acquired immunodeficiency syndrome who developed cyanosis as a result of methaemoglobinaemia immediately after bronchoscopy. This was probably due to systemic absorption of the topical anaesthetic used to anaesthetise the nasopharynx (benzocaisk') or the trachea (lignocaine).
Case report
A 30 year old man with the acquired immunodeficiency syndrome (AIDS) and chronic oropharyngeal candidiasis underwent bronchoscopy to evaluate new nodular densities on the chest radiograph. He denied recent use of amyl nitrite or other drugs. The nose and nasopharynx were anaesthetised with several sprays of Cetacaine topical anaesthetic (benzocaine 14% and tetracaine 2%). About 10 ml of a 2% solution of lignocaine (lidocaine USP) was given through the bronchoscope to anaesthetise the larynx and major airways. Multiple transbronchial biopsy specimens were obtained and bronchoalveolar lavage was performed without difficulty.
Immediately after bronchoscopy the patient became profoundly cyanosed. A chest radiograph showed no new infiltrate or pneumothorax. An arterial blood sample, obtained while the patient breathed ambient air, was chocolate brown in colour. The pH was 7-36, the arterial oxygen tension (Pao2) 11-2 kPa and the arterial carbon dioxide tension (Paco2) 5 Severe methaemoglobinaemia afterflexiblefibreoptic bronchoscopy Lignocaine occasionally causes methaemoglobinaemia in patients who are unusually susceptible to the disorder. 5 The mechanism of increased susceptibility is not always clear. A heterozygous form of NADH-methaemoglobin reductase deficiency is probably the most common cause. We were not able to measure the enzyme in our patient. Increased susceptibility to methaemoglobinaemia seems unlikely in that he could recall no previous episode of cyanosis despite prior injection ofthe drug for dental work and the suturing of skin lacerations.
Benzocaine is known to cause a dose related methaemoglobinaemia in normal individuals after parenteral administration or ingestion.5 The drug is widely used topically and in suppositories because it is minimally absorbed from intact skin or mucous membranes. Therapeutic doses ofbenzocaine have caused severe methaemoglobinaemia when systemic absorption across the stomach or rectum has been enhanced by the presence of gastritis or rectal fissures>' and even, occasionally, when the absorbing surface appeared normal.3 Excessive quantities ofbenzocaine were not used in this case. We suspect that Candida infection in this patient's oropharynx disrupted the mucosal surface sufficiently to cause excessive systemic absorption of the benzocaine and resulted in a dose related methaemoglobinaemia.
We 
